Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Colomycin 1million unit inj vials
0501070I0BBABAB
|
Colomycin (Parenteral) | Colistimethate sodium | Infections | 3,667 |
|
Metronidazole 200mg/5ml oral suspension
0501110C0AAAEAE
|
Metronidazole (Systemic) | Metronidazole | Infections | 3,439 |
|
Fluconazole 50mg/5ml oral suspension
0502010B0AAAGAG
|
Fluconazole | Fluconazole | Infections | 3,338 |
|
Fluconazole 200mg capsules
0502010B0AAACAC
|
Fluconazole | Fluconazole | Infections | 3,144 |
|
Paxlovid 150mg/100mg tablets
0503060B0BBAAAA
|
Paxlovid | Nirmatrelvir with Ritonavir | Infections | 3,022 |
|
Ciprofloxacin 250mg/5ml oral suspension
0501120L0AABGBG
|
Ciprofloxacin (Systemic) | Ciprofloxacin | Infections | 2,957 |
|
Erythromycin ethyl succinate 500mg tablets
0501050H0AAAEAE
|
Erythromycin ethylsuccinate | Erythromycin ethylsuccinate | Infections | 2,934 |
|
Co-trimoxazole 80mg/400mg/5ml oral suspension
0501080D0AAAEAE
|
Co-trimoxazole | Co-trimoxazole(Trimethoprim/sulfamethoxazole) | Infections | 2,782 |
|
Metronidazole 500mg tablets
0501110C0AABHBH
|
Metronidazole (Systemic) | Metronidazole | Infections | 2,757 |
|
Cefradine 250mg capsules
0501021M0AAAAAA
|
Cefradine | Cefradine | Infections | 2,672 |
|
Co-amoxiclav 400mg/57mg/5ml oral suspension sugar free
0501013K0AAAKAK
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 2,669 |
|
Vancomycin 125mg capsules
0501070U0AAAAAA
|
Vancomycin hydrochloride (Systemic) | Vancomycin hydrochloride | Infections | 2,504 |
|
Rifampicin 300mg capsules
0501090R0AAABAB
|
Rifampicin | Rifampicin | Infections | 2,424 |
|
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free
0501080D0AAACAC
|
Co-trimoxazole | Co-trimoxazole(Trimethoprim/sulfamethoxazole) | Infections | 2,407 |
|
Colomycin 2million unit inj vials
0501070I0BBACAE
|
Colomycin (Parenteral) | Colistimethate sodium | Infections | 2,346 |
|
Aciclovir 200mg/5ml oral suspension sugar free
0503021C0AAAAAA
|
Aciclovir (Systemic) | Aciclovir | Infections | 2,183 |
|
Oseltamivir 75mg capsules
0503040B0AAAAAA
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | 2,060 |
|
Minocycline 100mg modified-release capsules
0501030P0AAACAC
|
Minocycline hydrochloride (Systemic) | Minocycline hydrochloride | Infections | 1,846 |
|
Cefradine 500mg capsules
0501021M0AAABAB
|
Cefradine | Cefradine | Infections | 1,703 |
|
Macrobid 100mg modified-release capsules
0501130R0BGAAAG
|
Macrobid | Nitrofurantoin | Infections | 1,625 |
|
Demeclocycline 150mg capsules
0501030F0AAAAAA
|
Demeclocycline hydrochloride | Demeclocycline hydrochloride | Infections | 1,550 |
|
Dapsone 100mg tablets
0501100H0AAAHAH
|
Dapsone | Dapsone | Infections | 1,525 |
|
Colistimethate 1million unit inj vials
0501070I0AAABAB
|
Colistimeth sodium (Systemic) | Colistimethate sodium | Infections | 1,441 |
|
Levofloxacin 250mg tablets
0501120X0AAABAB
|
Levofloxacin | Levofloxacin | Infections | 1,392 |
|
Famciclovir 250mg tablets
0503021E0AAAAAA
|
Famciclovir | Famciclovir | Infections | 1,303 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.